ARABIAN-CHEMICAL
15.5.2024 20:34:30 CEST | Business Wire | Press release
Arabian Chemical Terminals LLC in Abu Dhabi (ACTAD) is proud to announce the start of operations at its newly built chemical tank storage terminal in Khalifa Port, Abu Dhabi, UAE. The terminal is the first commercial chemical tank farm of its kind in the Emirate.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240515922771/en/
ACT Abu Dhabi open for business (Photo: AETOSWire)
Strategically located in the new world class Khalifa Port and adjacent to the modern and sprawling Khalifa Economic Zone Abu Dhabi (KEZAD), ACTAD aims to participate in the drive to promote new industries in the Emirate.
ACTAD was designed and built as State of the Art in compliance with the highest international standards and boasts a total of 40 tanks of various specifications (20 Carbon Steel including 10 with IFR and 20 Stainless Steel including 10 insulated with heating/cooling system) for a total of 100,000 CBM storage capacity. Each tank has a devoted pipeline to a dedicated berth of 16 meters draft and dedicated truck loading bays, therefore, eliminating the risks of cross product contamination, promoting maximum operating efficiency and flexibility to the customers.
Additionally, the site has a 500 sqm warehouse for dangerous goods and provision for drums/IBCs filling.
The terminal has an independently operated third party fully equipped surveyor laboratory for sampling and testing.
ACTAD operates with an Integrated Management System following International Standards; ISO-9000, 14000, 18000, CDI-T and ISGOTT.
The Terminal will help local industries to import their liquid chemical needs in bulk or export their liquid chemical products to the globe. It can also act as a storage hub and/or break-bulk operations for international companies as it is strategically located in a bonded zone within Khalifa Port.
ACTAD is an extension of Arabian Chemical Terminals LTD in Saudi Arabia (ACT-KSA). ACT-KSA is an owner/operator of two other terminals, one in Yanbu on the Red Sea coast and one in Jubail Commercial Port on the Arabian Gulf. From its humble beginnings in 1986 in Yanbu, ACT-KSA was the first commercial tank farm established in Saudi Arabia, starting with 13,000 CBM of storage capacity. In 2012 ACT-KSA built the first commercial bulk storage facility in Jubail adding a further 70,000 CBM of storage capacity with tanks varying in specifications and in sizes. The Jubail terminal is currently under expansion to add a further 70,000 CBM of capacity.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515922771/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom